Drug intelligence / Profile preview

UMC119-06-05

Development stage: Phase 2
Lead developer: Meribank Biotech
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous, Intraarticular

Overview

UMC119-06-05 is an allogeneic cell therapy product consisting of ex vivo cultured human umbilical cord tissue-derived mesenchymal stem cells (HUC-MSCs). Developed by Meridigen Biotech (also known as Meribank Biotech), the therapy leverages the immunomodulatory, anti-inflammatory, and regenerative properties of mesenchymal stem cells to address conditions characterized by systemic or local inflammation and tissue degeneration. UMC119-06-05 is currently being evaluated in clinical trials for the treatment of frailty syndrome in elderly populations, where it is administered via intravenous infusion to improve functional outcomes and reduce frailty-associated biomarkers. Additionally, it is under investigation for mild to moderate knee osteoarthritis, delivered through intra-articular injection to promote joint repair and alleviate symptoms.

Other names: allogeneic umbilical cord mesenchymal stem cellshuman umbilical cord tissue-derived mesenchymal stem cellsHUC-MSCs

Beyond the preview

Go deeper on UMC119-06-05.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UMC119-06-05.

Explore the full profile